ARCHIVES

Phase III Trial Would Give Clearer Picture Of C225 Role.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director

March 17, 1995

CAN-DIAL Test Generates 16,000 Calls for Cancer Information

December 13, 1974

In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month

August 14, 1992

Prevention Task Force Unable To Reach Consensus On New Division, Tries To Avoid More Disruption

July 6, 1979

NIH To Correct Factual Errors In Jackson Lab Policy Statement

August 18, 1989

Kennedy Tells ASCO Members To Lobby For High Tar, Nicotine Tax

April 7, 1978